19 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
to realize the benefit of such transactions if it is unable to successfully integrate them with its existing
operations and company culture. Any
8-K
EX-10.2
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
team with great confidence in your abilities to have a major impact on our mission and the special culture we are building.
Duties and Extent of Service
424B3
fxwg9wmat45 5lk
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
adjj4i39awc6 jpv
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.31
2m2jf2
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.32
4fx1i
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
DEF 14A
tnv8hs45tyzg4w vzr
27 Apr 22
Definitive proxy
4:04pm
424B4
8im01
5 Feb 21
Prospectus supplement with pricing info
5:12pm
DRS/A
0r4w7ahfwlxalexoa
15 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
8ieu2eepg
13 May 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next